triple-negative breast cancer: adding carboplatin to presurgery chemotherapy improved survival
Published 8 years ago • 3.3K plays • Length 7:23Download video MP4
Download video MP3
Similar videos
-
8:55
survival outcomes from the calgb 40603 study in triple-negative breast cancer
-
2:52
neoadjuvant and adjuvant therapy in triple negative breast cancer
-
8:05
keynote-522: immune therapy and chemotherapy in patients with early triple negative breast cancer
-
6:52
immunotherapy added to chemotherapy improves pathological complete response in early triple nega...
-
1:18
triple-negative breast cancer may have new treatment option
-
9:57
sudeep gupta, sabcs 2022: addition of platinum to chemotherapy in triple-negative breast cancer
-
3:11
results of the create-x trial
-
8:51
impact of adding bevacizumab to presurgery chemo for 3n bc varies with subtype
-
1:56
dr. eric winer on carboplatin and/or bevacizumab in triple-negative breast cancer
-
7:40
study of carboplatin plus nivolumab in metastatic triple-negative breast cancer
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
3:47
parp inhibitory velaparib trialled in brca1/2 breast cancer
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
3:50
comment: veliparib with carboplatin and paclitaxel in advanced gbrca-positive breast cancers
-
9:50
impact of adding bevacizumab to presurgery chemo for 3n bc varies with subtype
-
0:53
enhancing triple negative breast cancer treatment with immunotherapy across all settings
-
1:34
is carboplatin an effective addition in the treatment of breast cancer?
-
3:36
cisplatin /- veliparib in metastatic tnbc and/or germline brca-associated breast cancer
-
4:54
keynote-522 updates: pembrolizumab plus neoadjuvant chemotherapy in early triple-negative breast...